Chemotherapy combined with dendritic cell vaccine and cytokine-induced killer cells in the treatment of colorectal carcinoma: a meta-analysis

References

• BotrelTEClarkOPompeoACImmunotherapy with Sipuleucel-T (APC8015) in patients with metastatic castration-refractory prostate cancer (mCRPC): a systematic review and meta-analysisInt Braz J Urol201238671772723302410
   PubMed Web of Science ®Google Scholar
• ChenLZhangXPrimary analysis for clinical efficacy of immunotherapy in patients with pancreatic cancerImmunotherapy20168222323426565954
   PubMed Web of Science ®Google Scholar
• Couzin-FrankelJBreakthrough of the year 2013. Cancer immunotherapyScience201334261651432143324357284
   PubMed Web of Science ®Google Scholar
• CuiYYangXZhuWLiJWuXPangYImmune response, clinical outcome and safety of dendritic cell vaccine in combination with cytokine-induced killer cell therapy in cancer patientsOncol Lett20136253754124137363
   PubMed Web of Science ®Google Scholar
• EllebaekEAndersenMHSvaneIMStratenPTImmunotherapy for metastatic colorectal cancer: present status and new optionsScand J Gastroenterol201247331532422214467
   PubMed Web of Science ®Google Scholar
• FongLHouYRivasAAltered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapyProc Natl Acad Sci U S A200198158809881411427731
   PubMed Web of Science ®Google Scholar
• GalluzziLVacchelliEEggermontATrial Watch: Adoptive cell transfer immunotherapyOncoimmunology20121330631522737606
   PubMed Web of Science ®Google Scholar
• GaoDLiCXieXAutologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patientsPLoS One201494e9388624699863
   PubMed Web of Science ®Google Scholar
• GaoJBernatchezCSharmaPRadvanyiLGHwuPAdvances in the development of cancer immunotherapiesTrends Immunol2013342909823031830
   PubMed Web of Science ®Google Scholar
• HarrisJERyanLHooverHCAdjuvant Active Specific Immunotherapy for Stage II and III Colon Cancer with an Autologous Tumor Cell Vaccine: Eastern Cooperative Oncology Group Study E5283J Clin Oncol20001814815710623705
   PubMed Web of Science ®Google Scholar
• HontschaCBorckYZhouHMessmerDSchmidt-WolfIGClinical trials on CIK cells: first report of the international registry on CIK cells (IRCC)J Cancer Res Clin Oncol2011137230531020407789
   PubMed Web of Science ®Google Scholar
• JadadARMooreRACarrollDAssessing the quality of reports of randomized clinical trials: is blinding necessary?Control Clin Trials19961711128721797
   PubMedGoogle Scholar
• KirkwoodJMButterfieldLHTarhiniAAZarourHKalinskiPFerroneSImmunotherapy of cancer in 2012CA Cancer J Clin201262530933522576456
   PubMed Web of Science ®Google Scholar
• LanXPChenYGWangZImmunotherapy of DC-CIK cells enhances the efficacy of chemotherapy for solid cancer: a meta-analysis of randomized controlled trials in Chinese patientsJ Zhejiang Univ Sci B201516974375626365116
   PubMed Web of Science ®Google Scholar
• LesterhuisWJHaanenJBPuntCJCancer immunotherapy – revisitedNat Rev Drug Discov201110859160021804596
   PubMed Web of Science ®Google Scholar
• LiXDaiXShiLPhase II/III Study of Radiofrequency Ablation Combined with Cytokine-Induced Killer Cells Treating Colorectal Liver MetastasesCell Physiol Biochem2016401–213714527855365
   PubMedGoogle Scholar
• LinTSongCChuoDYZhangHZhaoJClinical Effects of Autologous Dendritic Cells Combined with Cytokine-Induced Killer Cells Followed by Chemotherapy in Treating Patients with Advanced Colorectal Cancer: A Prospective StudyTumour Biol20163744367437226499782
   PubMedGoogle Scholar
• LuPHNegrinRSA novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiencyJ Immunol19941534168716967519209
   PubMed Web of Science ®Google Scholar
• MaggiET-cell responses induced by allergen-specific immunotherapyClin Exp Immunol20101611101820408857
   PubMed Web of Science ®Google Scholar
• MaoQLiLZhangCSunYLiuSCuiSClinical effects of immunotherapy of DC-CIK combined with chemotherapy in treating patients with metastatic breast cancerPak J Pharm Sci2015283 Suppl1055105826051718
   PubMed Web of Science ®Google Scholar
• MargolinKANegrinRSWongKKChatterjeeSWrightCFormanSJCellular immunotherapy and autologous transplantation for hematologic malignancyImmunol Rev19971572312409255634
   PubMed Web of Science ®Google Scholar
• MellmanICoukosGDranoffGCancer immunotherapy comes of ageNature2011480737848048922193102
   PubMed Web of Science ®Google Scholar
• MosolitsSNilssonBMellstedtHTowards therapeutic vaccines for colorectal carcinoma: a review of clinical trialsExpert Rev Vaccines20054332935016026248
   PubMed Web of Science ®Google Scholar
• MuYZhouCHChenSFEffectiveness and safety of chemotherapy combined with cytokine-induced killer cell /dendritic cell-cytokine-induced killer cell therapy for treatment of gastric cancer in China: a systematic review and meta-analysisCytotherapy20161891162117727421742
   PubMed Web of Science ®Google Scholar
• NiuJRenYZhangTRetrospective comparative study of the effects of dendritic cell vaccine and cytokine-induced killer cell immunotherapy with that of chemotherapy alone and in combination for colorectal cancerBiomed Res Int20142014214727725210706
   PubMed Web of Science ®Google Scholar
• O’BrienCAPollettAGallingerSDickJEA human colon cancer cell capable of initiating tumour growth in immunodeficient miceNature2007445712310611017122772
   PubMed Web of Science ®Google Scholar
• PaluckaKBanchereauJDendritic-cell-based therapeutic cancer vaccinesImmunity2013391384823890062
   PubMed Web of Science ®Google Scholar
• PievaniABorleriGPendeDDual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicityBlood2011118123301331021821703
   PubMed Web of Science ®Google Scholar
• PyzerARAviganDERosenblattJClinical trials of dendritic cell-based cancer vaccines in hematologic malignanciesHum Vaccin Immunother201410113125313125625926
   PubMed Web of Science ®Google Scholar
• RaberPLSierraRAThevenotPTT cells conditioned with MDSC show an increased anti-tumor activity after adoptive T cell based immunotherapyOncotarget2016714175651757827007050
   PubMedGoogle Scholar
• Schmidt-WolfIGLefterovaPMehtaBAPhenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cellsExp Hematol19932113167316797694868
   PubMed Web of Science ®Google Scholar
• SchmidtJEisoldSBüchlerMWMärtenADendritic cells reduce number and function of CD4+CD25+ cells in cytokine-induced killer cells derived from patients with pancreatic carcinomaCancer Immunol Immunother200453111018102615185013
   PubMed Web of Science ®Google Scholar
• SchulerPJHarasymczukMVisusCPhase I dendritic cell p53 peptide vaccine for head and neck cancerClin Cancer Res20142092433244424583792
   PubMed Web of Science ®Google Scholar
• SevčíkováKUšákováVBartošováZSurgical treatment of metastases and its impact on prognosis in patients with metastatic colorectal carcinomaKlin Onkol2014271384424635436
   PubMedGoogle Scholar
• SharifSO’ConnellMJYothersGLopaSWolmarkNFOLFOX and FLOX regimens for the adjuvant treatment of resected stage II and III colon cancerCancer Invest200826995696318798075
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKDJemalACancer Statistics, 2017CA Cancer J Clin201767173028055103
   PubMed Web of Science ®Google Scholar
• StangACritical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEur J Epidemiol201025960360520652370
   PubMed Web of Science ®Google Scholar
• SteinmanRMBanchereauJTaking dendritic cells into medicineNature2007449716141942617898760
   PubMed Web of Science ®Google Scholar
• ThanendrarajanSKimYSchmidt-WolfINew adoptive immunotherapy strategies for solid tumours with CIK cellsExpert Opin Biol Ther201212556557222444075
   PubMed Web of Science ®Google Scholar
• ThomasAAErnstoffMSFadulCEImmunotherapy for the treatment of glioblastomaCancer J2012181596822290259
   PubMed Web of Science ®Google Scholar
• ThurnerBHaendleIRöderCVaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanomaJ Exp Med1999190111669167810587357
   PubMed Web of Science ®Google Scholar
• TierneyJFStewartLAGhersiDBurdettSSydesMRPractical methods for incorporating summary time-to-event data into meta-analysisTrials200781617555582
   PubMed Web of Science ®Google Scholar
• TimmermanJMCzerwinskiDKDavisTAIdiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patientsBlood20029951517152611861263
   PubMed Web of Science ®Google Scholar
• ToomeyPGVohraNAGhansahTSarnaikAAPilon-ThomasSAImmunotherapy for gastrointestinal malignanciesCancer Control2013201324223302905
   PubMed Web of Science ®Google Scholar
• WangHZhouFJWangQJEfficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma – a report of ten casesAi Zheng200625562563016687087
   PubMedGoogle Scholar
• WangQJWangHPanKComparative study on anti-tumor immune response of autologous cytokine-induced killer (CIK) cells, dendritic cells-CIK (DC-CIK), and semi-allogeneic DC-CIKChin J Cancer201029764164820591215
   PubMedGoogle Scholar
• WeiXCYangDDHanXRBioactivity of umbilical cord blood dendritic cells and anti-leukemia effectInt J Clin Exp Med2015810197251973026770637
   PubMed Web of Science ®Google Scholar
• XiangBSnookAEMageeMSWaldmanSAColorectal cancer immunotherapyDiscov Med2013158430130823725603
   PubMed Web of Science ®Google Scholar
• ZhangLYangXSunZDendritic cell vaccine and cytokine-induced killer cell therapy for the treatment of advanced non-small cell lung cancerOncol Lett20161142605261027073525
   PubMed Web of Science ®Google Scholar
• ZhangLZhuWLiJClinical outcome of immunotherapy with dendritic cell vaccine and cytokine-induced killer cell therapy in hepatobiliary and pancreatic cancerMol Clin Oncol20164112913326870371
   PubMedGoogle Scholar
• ZhangYWangJWangYAutologous CIK cell immunotherapy in patients with renal cell carcinoma after radical nephrectomyClin Dev Immunol2013201319569124382970
   PubMedGoogle Scholar
• ZhaoHWangYYuJAutologous Cytokine-Induced Killer Cells Improves Overall Survival of Metastatic Colorectal Cancer Patients: Results From a Phase II Clinical TrialClin Colorectal Cancer201615322823527052743
   PubMed Web of Science ®Google Scholar
• ZhouCLiuDLiJChemotherapy plus dendritic cells co-cultured with cytokine-induced killer cells versus chemotherapy alone to treat advanced non-small-cell lung cancer: a meta-analysisOncotarget2016752865008651027863436
   PubMedGoogle Scholar
• ZhuHYangXLiJSafety, and Survival and Quality of Life Outcomes for Advanced Colorectal Cancer Patients Treated with Dendritic Cell Vaccine and Cytokine-Induced Killer Cell TherapyBiomed Res Int2014201460387125136601
   PubMed Web of Science ®Google Scholar
• ZhouZZhangTLiBExtracting and transforming of appropriate data of Meta-analysis in survival curveChin J Evid Based Cardiovasc Med20146243247 Chinese [with English abstract]
   Google Scholar